{
}
Tidjane Thiam, former CEO of Credit Suisse, allegedly ordered the surveillance of his girlfriend's ex-husband shortly after taking office in 2016, a plan that remained hidden until the 2019 exposure of another spying incident. The ongoing trial in Washington, where the ex-husband claims $15 million in damages, reveals a troubling culture of espionage within the bank, suggesting that such practices may have been prevalent even before Thiam's tenure. UBS, as the legal successor, now faces the fallout from these revelations, tarnishing its reputation in the critical U.S. financial market.
Thomas Gottstein's refusal to support a merger between UBS and Credit Suisse (CS) in 2020 marked the beginning of CS's decline, as he believed he could independently steer the bank back to stability. Despite significant losses from the Greensill and Archegos scandals, he remained CEO until 2022, while Urs Rohner, the Chairman, failed to hold him accountable. Ultimately, UBS acquired CS for a mere $3 billion amid the fallout from the Silicon Valley banking crisis, highlighting the missteps of both Gottstein and Rohner in navigating the bank's challenges.
Credit Suisse (CS) faced severe liquidity issues during the Covid crisis, being the only global systemically important bank unable to meet its requirements, which led to failed merger talks with UBS in 2020. UBS later acquired CS in 2023, benefiting from the latter's weakened state and government guarantees, avoiding the risks and costs associated with a merger three years earlier. UBS's management had long viewed CS as doomed, particularly after its 2015 strategy under Tidjane Thiam, which was seen as a dead end.
Switzerland stands out as the highest-paying country for CEOs, with compensation packages that far exceed those in the USA and UK. The top earners, Severin Schwan of Roche and Juan Carlos Torres Carretero of Avolta, each earn 5.7 million francs, attracting corporate leaders from across Europe.
Severin Schwan's leadership at Roche faces scrutiny amid declining stock prices and research setbacks, contrasting with competitors like Novo Nordisk and Eli Lilly. While Schwan's cautious approach has fostered stability, analysts question the pipeline's potential for future blockbuster drugs, leaving Roche's growth prospects uncertain.
Roche, under CEO Thomas Schinecker, is streamlining its operations by focusing on five key therapeutic areas: neurology, oncology, eye diseases, immunology, and cardiovascular/metabolic diseases. The company is prioritizing promising drugs like CT-388, an injection aimed at significant weight loss, while addressing internal inefficiencies and aiming for faster clinical trials. Despite setbacks, Roche is determined to enhance its drug pipeline and maintain competitive growth in the pharmaceutical market.
Severin Schwan
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
credit suisse scandal reveals extensive surveillance operations under ceo tidjane thiam
Microsoft Corporation
Hoffmann-La Roche AG
Credit Suisse Anlagestiftung
UBS AG
USA
Thomas Gottstein
Pierre-Olivier Bouée
Tidjane Thiam
Severin Schwan
Urs Rohner
Iqbal Khan
Show more
07:59 06.11.2024
gottstein's refusal to merge accelerates downfall of credit suisse
United States Dollar
UBS AG
Hoffmann-La Roche AG
CS Baumann
CHE
Thomas Gottstein
Axel Weber
Sergio Ermotti
Ueli Maurer
Severin Schwan
Show more
07:59 29.10.2024
ubs avoids merger with credit suisse in 2020 amid liquidity concerns
Swiss Franc
Prudential Ltd.
UBS AG
Hoffmann-La Roche AG
Credit Suisse Anlagestiftung
CHE
Thomas Gottstein
Tidjane Thiam
Ralph Hamers
Sergio Ermotti
Severin Schwan
Show more
05:30 29.10.2024
switzerland's top ceos earn record salaries attracting global talent
08:00 26.10.2024
Roche's leadership under Schwan faces scrutiny amid research setbacks and stock decline
Swiss Franc
Eli Lilly and Company
Hoffmann-La Roche AG
Novo Nordisk A/S
Credit Suisse Anlagestiftung
Flatiron Baseball LLC
CHE
DEU
Alain Berset
Severin Schwan
Ignazio Cassis
Thomas Schinecker
Guy Parmelin
Show more
09:00 05.10.2024
Roche's new strategy focuses on promising drugs and streamlined research efforts
09:00 02.10.2024
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Finance Mergers & Acquisitions
Hedge Funds & Private Equity
Global Trade Developments
Global Financial Events
Market Analysis and Predictions
Financial Scams and Security
Government Policies
Banking Regulations
Economic Sanctions
CEO Changes
Retail and Consumer Goods
Startups & Entrepreneurship
Industry Mergers & Acquisitions
International Relations
Central Bank Actions
Workplace Trends
Domestic Politics
Countries:
Companies:
JPMorgan Chase & Co.
Tesla, Inc.
The Goldman Sachs Group, Inc.
Wells Fargo & Company
Bank of America Corporation
Barclays PLC
Apple Inc.
Morgan Stanley
Citigroup Inc.
Berkshire Hathaway Inc.
Microsoft Corporation
SpaceXCoin USD
The Charles Schwab Corporation
AMERICAN EXPRESS
Amazon.com, Inc.
U.S. Bancorp
UBS Group AG
Banco Santander, S.A.
Deutsche Bank Money Market PP
Citizens, Inc.
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Japanese Yen
British Pound Sterling
South Korean Won
Swiss Franc
United Arab Emirates Dirham
Canadian Dollar
Israeli New Shekel
Swedish Krona
Mexican Peso
New Taiwan Dollar
People: